These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35522139)

  • 1. Interobserver Variability in CT-based Morphologic Tumor Response Assessment of Colorectal Liver Metastases.
    Wesdorp NJ; Kemna R; Bolhuis K; van Waesberghe JHTM; Nota IMGC; Struik F; Oulad Abdennabi I; Phoa SSKS; van Dieren S; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Swijnenburg RJ; Punt CJA; Huiskens J; Stoker J; Kazemier G;
    Radiol Imaging Cancer; 2022 May; 4(3):e210105. PubMed ID: 35522139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases.
    Chun YS; Vauthey JN; Boonsirikamchai P; Maru DM; Kopetz S; Palavecino M; Curley SA; Abdalla EK; Kaur H; Charnsangavej C; Loyer EM
    JAMA; 2009 Dec; 302(21):2338-44. PubMed ID: 19952320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deep learning models for automatic tumor segmentation and total tumor volume assessment in patients with colorectal liver metastases.
    Wesdorp NJ; Zeeuw JM; Postma SCJ; Roor J; van Waesberghe JHTM; van den Bergh JE; Nota IM; Moos S; Kemna R; Vadakkumpadan F; Ambrozic C; van Dieren S; van Amerongen MJ; Chapelle T; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Marquering HA; Stoker J; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Eur Radiol Exp; 2023 Dec; 7(1):75. PubMed ID: 38038829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prognostic Value of Total Tumor Volume Response Compared With RECIST1.1 in Patients With Initially Unresectable Colorectal Liver Metastases Undergoing Systemic Treatment.
    Wesdorp NJ; Bolhuis K; Roor J; van Waesberghe JTM; van Dieren S; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grunhagen D; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Liem MSL; van Lienden KP; Molenaar IQ; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Swijnenburg RJ; Punt CJA; Huiskens J; Kazemier G
    Ann Surg Open; 2021 Dec; 2(4):e103. PubMed ID: 37637880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Semi-automatic software increases CT measurement accuracy but not response classification of colorectal liver metastases after chemotherapy.
    van Kessel CS; van Leeuwen MS; Witteveen PO; Kwee TC; Verkooijen HM; van Hillegersberg R
    Eur J Radiol; 2012 Oct; 81(10):2543-9. PubMed ID: 22264447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Morphologic response to chemotherapy containing bevacizumab in patients with colorectal liver metastases: A post hoc analysis of the WJOG4407G phase III study.
    Hosokawa A; Yamazaki K; Matsuda C; Ueda S; Kusaba H; Okamura S; Tsuda M; Tamura T; Shinozaki K; Tsushima T; Tsuda T; Shirakawa T; Yamashita H; Morita S; Hironaka S; Muro K
    Medicine (Baltimore); 2020 Sep; 99(36):e22060. PubMed ID: 32899071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of the tumor-to-liver density ratio in patients with metastatic colorectal cancer treated with bevacizumab-based chemotherapy. A post-hoc study of the STIC-AVASTIN trial.
    Mazard T; Mollevi C; Loyer EM; Léger J; Chautard R; Bouché O; Borg C; Armand-Dujardin P; Bleuzen A; Assenat E; Lecomte T
    Cancer Imaging; 2024 Jun; 24(1):77. PubMed ID: 38886836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non Size Based Morphology Criteria for Assessment of Response in Patients with Liver Metastases of Gastrointestinal Origin Receiving Systemic Treatment.
    Alhanafy A; Abdullah MS; Hafez H; Abbas H
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1655-1660. PubMed ID: 29938450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suitability of semi-automated tumor response assessment of liver metastases using a dedicated software package.
    Kalkmann J; Ladd SC; de Greiff A; Forsting M; Stattaus J
    Rofo; 2010 Jul; 182(7):581-8. PubMed ID: 20419616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
    Huiskens J; van Gulik TM; van Lienden KP; Engelbrecht MR; Meijer GA; van Grieken NC; Schriek J; Keijser A; Mol L; Molenaar IQ; Verhoef C; de Jong KP; Dejong KH; Kazemier G; Ruers TM; de Wilt JH; van Tinteren H; Punt CJ
    BMC Cancer; 2015 May; 15():365. PubMed ID: 25943574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of total tumor volume in patients with colorectal liver metastases: A secondary analysis of the randomized CAIRO5 trial with external cohort validation.
    Michiel Zeeuw J; Wesdorp NJ; Ali M; Bakker AJJ; Voigt KR; Starmans MPA; Roor J; Kemna R; van Waesberghe JHTM; van den Bergh JE; Nota IMGC; Moos SI; van Dieren S; van Amerongen MJ; Bond MJG; Chapelle T; van Dam RM; Engelbrecht MRW; Gerhards MF; van Gulik TM; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Quintus Molenaar I; Patijn GA; Rijken AM; Ruers TM; de Wilt JHW; Verpalen IM; Stoker J; Grunhagen DJ; Swijnenburg RJ; Punt CJA; Huiskens J; Verhoef C; Kazemier G
    Eur J Cancer; 2024 Aug; 207():114185. PubMed ID: 38924855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
    Bond MJG; Kuiper BI; Bolhuis K; Komurcu A; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik T; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Kazemier G; May AM; Punt CJA; Swijnenburg RJ
    Ann Surg Oncol; 2023 Sep; 30(9):5376-5385. PubMed ID: 37118612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of inter-observer variability according to RECIST 1.1 and its influence on response classification in CT measurement of liver metastases.
    Bellomi M; De Piano F; Ancona E; Lodigiani AF; Curigliano G; Raimondi S; Preda L
    Eur J Radiol; 2017 Oct; 95():96-101. PubMed ID: 28987705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of colorectal liver metastases using MRI and CT: impact of observer experience on diagnostic performance and inter-observer reproducibility with histopathological correlation.
    Albrecht MH; Wichmann JL; Müller C; Schreckenbach T; Sakthibalan S; Hammerstingl R; Bechstein WO; Zangos S; Ackermann H; Vogl TJ
    Eur J Radiol; 2014 Oct; 83(10):1752-8. PubMed ID: 25082480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative margin assessment of radiofrequency ablation of a solitary colorectal hepatic metastasis using MIRADA RTx on CT scans: a feasibility study.
    Sibinga Mulder BG; Hendriks P; Baetens TR; van Erkel AR; van Rijswijk CSP; van der Meer RW; van de Velde CJH; Vahrmeijer AL; Mieog JSD; Burgmans MC
    BMC Med Imaging; 2019 Aug; 19(1):71. PubMed ID: 31429708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surrogate Imaging Biomarkers of Response of Colorectal Liver Metastases After Salvage Radioembolization Using 90Y-Loaded Resin Microspheres.
    Shady W; Sotirchos VS; Do RK; Pandit-Taskar N; Carrasquillo JA; Gonen M; Sofocleous CT
    AJR Am J Roentgenol; 2016 Sep; 207(3):661-70. PubMed ID: 27384594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Imaging to Predict Complete Response of Colorectal Liver Metastases after Chemotherapy: MR Imaging versus CT Imaging.
    Park MJ; Hong N; Han K; Kim MJ; Lee YJ; Park YS; Rha SE; Park S; Lee WJ; Park SH; Lee CH; Nam CM; An C; Kim HJ; Kim H; Park MS
    Radiology; 2017 Aug; 284(2):423-431. PubMed ID: 28327002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraobserver and interobserver variability in computed tomography size and attenuation measurements in patients with renal cell carcinoma receiving antiangiogenic therapy: implications for alternative response criteria.
    Krajewski KM; Nishino M; Franchetti Y; Ramaiya NH; Van den Abbeele AD; Choueiri TK
    Cancer; 2014 Mar; 120(5):711-21. PubMed ID: 24264883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation between CT morphologic appearance and histologic findings in colorectal liver metastasis after preoperative chemotherapy.
    Ishida K; Tamura A; Kato K; Uesugi N; Osakabe M; Eizuka M; Hasegawa Y; Nitta H; Otsuka K; Sasaki A; Ehara S; Sugai T
    Abdom Radiol (NY); 2018 Nov; 43(11):2991-3000. PubMed ID: 29616287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapy.
    Mazard T; Assenat E; Dupuy M; Mollevi C; René A; Adenis A; Chauffert B; Boucher E; Francois E; Pierga JY; Ducreux M; Ychou M; Gallix B
    Dig Liver Dis; 2019 Aug; 51(8):1185-1191. PubMed ID: 31085108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.